MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 10-21-2025
Quest Diagnostics Incorporated Operating Cycle 2011-2026 | DGX
Annual Operating Cycle Quest Diagnostics Incorporated
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 56.9 | 58.7 | 59.9 | 62 | 60.8 | 59.1 | 56.4 | 51.1 | 51.5 | 50.5 | 54.4 | 51.2 | 50.6 | 51.5 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 62 | 50.5 | 55.3 |
Quarterly Operating Cycle Quest Diagnostics Incorporated
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 55.7 | 56.1 | 57.3 | 59.4 | 60.7 | 60.6 | 60.9 | 59.6 | 59.1 | - | 28.6 | 31.1 | 60.3 | - | 55.9 | 59.5 | 61.2 | 46.2 | 62.7 | 92.6 | 77.1 | 50.4 | 58.5 | 58.5 | 58.2 | 50.2 | 56.3 | 55.4 | 54.1 | 45.2 | 52.7 | 52.6 | 53.4 | 45.4 | 51.3 | 50.8 | 51.4 | 44.5 | 50.3 | 49.2 | 53.1 | 45.2 | 53.2 | 53.3 | 55 | 44.3 | 51.1 | 50.4 | 51.6 | 44.6 | 51.3 | 49.8 | 49.9 | 44.8 | 50.7 | 50.8 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 92.6 | 28.6 | 53.6 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
489 | - | -61.36 % | $ 2.46 M |  USA |
 |
Danaher Corporation
DHR
|
150 | $ 237.64 | 1.12 % | $ 174 B | USA |
 |
DarioHealth Corp.
DRIO
|
251 | $ 12.15 | -5.81 % | $ 345 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
275 | $ 23.25 | -0.66 % | $ 250 M |  China |
 |
DexCom
DXCM
|
204 | $ 66.95 | -2.16 % | $ 25.8 B | USA |
 |
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
329 | $ 1.59 | -0.94 % | $ 2.02 M | USA |
 |
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | USA |
 |
Co-Diagnostics
CODX
|
405 | $ 6.12 | - | $ 180 M | USA |
 |
IQVIA Holdings
IQV
|
78 | $ 243.33 | 0.06 % | $ 44.1 B | USA |
 |
Castle Biosciences
CSTL
|
97.9 | $ 39.59 | -0.76 % | $ 1.1 B | USA |
 |
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M | China |
 |
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | USA |
 |
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | USA |
 |
Natera
NTRA
|
81.5 | $ 234.65 | -2.05 % | $ 23.1 B | USA |
 |
CareDx, Inc
CDNA
|
76.4 | $ 17.02 | -1.16 % | $ 915 M | USA |
 |
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | USA |
 |
Pacific Biosciences of California
PACB
|
183 | $ 1.95 | -4.66 % | $ 495 M | USA |
 |
Anixa Biosciences
ANIX
|
385 | $ 3.41 | -0.29 % | $ 109 K | USA |
 |
Exact Sciences Corporation
EXAS
|
269 | $ 102.13 | 0.34 % | $ 18.9 B | USA |
 |
Fulgent Genetics
FLGT
|
77.4 | $ 27.84 | -0.2 % | $ 842 M | USA |
 |
QIAGEN N.V.
QGEN
|
172 | $ 48.32 | -0.27 % | $ 10.8 B |  Niderland |
 |
RadNet
RDNT
|
34.9 | $ 77.42 | -1.22 % | $ 5.65 B | USA |
 |
Guardant Health
GH
|
49.1 | $ 110.18 | 1.32 % | $ 13.5 B | USA |
 |
Aspira Women's Health
AWH
|
73.8 | - | -6.19 % | $ 10.5 M | USA |
 |
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
198 | $ 141.01 | -3.31 % | $ 22.4 B | USA |
 |
Charles River Laboratories International
CRL
|
67.7 | $ 220.64 | 2.38 % | $ 11.3 B | USA |
 |
Thermo Fisher Scientific
TMO
|
69.8 | $ 620.69 | 2.34 % | $ 237 B | USA |
 |
Trinity Biotech plc
TRIB
|
299 | $ 0.73 | -1.13 % | $ 61.9 M |  Irlanda |
 |
Twist Bioscience Corporation
TWST
|
96.1 | $ 35.58 | 2.42 % | $ 2.13 B | USA |
|
Biodesix
BDSX
|
41.7 | $ 5.46 | -2.15 % | $ 708 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
72.9 | $ 252.61 | -0.81 % | $ 21.2 B | USA |
 |
ICON Public Limited Company
ICLR
|
68.5 | $ 183.13 | -2.7 % | $ 15.1 B | Irlanda |
 |
IDEXX Laboratories
IDXX
|
135 | $ 715.47 | 0.43 % | $ 59 B | USA |
 |
Lantheus Holdings
LNTH
|
116 | $ 67.98 | 0.19 % | $ 4.7 B | USA |
 |
Agilent Technologies
A
|
161 | $ 148.92 | 2.17 % | $ 45.3 B | USA |
 |
Biomerica
BMRA
|
204 | $ 2.75 | -4.84 % | $ 6.32 M | USA |
 |
Bioventus
BVS
|
267 | $ 8.02 | 0.25 % | $ 502 M | USA |